Newest GLP-1 studies
21 randomized trials, meta-analyses and systematic reviews on GLP-1s were published in the last 30 days among those we track: 7 randomized trials, 12 meta-analyses and 2 systematic reviews. Read from PubMed every day, each linked to its own record.
Randomized trials, meta-analyses and systematic reviews
As published, listed from Europe PMC. A listing is not a judgement of a study's quality or a recommendation.
- Semaglutide and Cardiovascular Death: a Systematic Review and Meta-Analysis Cardioprotective Efficacy of Semaglutide
Meta-analysis · Crit Pathw Cardiol · Nov 2, 2026 · Marino G et al.
- Efficacy and safety of semaglutide versus placebo in adults with overweight or obesity without diabetes: updated meta-analysis of randomized trials
Meta-analysis · J Diabetes Metab Disord · Oct 31, 2026 · Wajid R et al.
- Efficacy and safety of oral orforglipron in Japanese participants with obesity disease (ATTAIN-J): a double-blind, randomised, placebo-controlled, parallel-group, phase 3 trial
Randomized trial · Lancet Diabetes Endocrinol · Oct 30, 2026 · Yokote K et al.
- A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Acmopatide (CT-868), a Fully Biased GLP-1/GIP Receptor Agonist, in Adults With Type 1 Diabetes and Overweight or Obesity
Randomized trial · Diabetes Care · Oct 28, 2026 · Klein KR et al.
- Cardiovascular Effects of GLP-1 Receptor Agonists Across Age Groups: An Updated Meta-Analysis of Randomized Controlled Trials
Meta-analysis · Diabetes Obes Metab · Oct 27, 2026 · Fujii A et al.
- [Efficacy and safety of domestic semaglutide injection in patients with type 2 diabetes mellitus inadequately controlled with metformin: a multicenter, randomized, controlled phase 3 equivalence clinical trial]
Randomized trial · Zhonghua Yi Xue Za Zhi · Oct 26, 2026 · Wang WM et al.
- Effect of glucagon-like-peptide-1 receptor agonists on major cardiovascular outcomes: a systematic review and meta-analysis
Meta-analysis · Monaldi Arch Chest Dis · Oct 26, 2026 · Saleem MF et al.
- Efficacy and safety of GLP-1 receptor agonists for antipsychotic-related overweight and metabolic dysregulation: a systematic review and meta-analysis
Meta-analysis · Eur J Clin Pharmacol · Oct 24, 2026 · Zhou L et al.
- Efficacy and safety of GLP-1 receptor agonists in patients with schizophrenia spectrum disorders treated with antipsychotics: a systematic review and meta-analysis
Meta-analysis · Eur Neuropsychopharmacol · Oct 24, 2026 · Gędek A et al.
- Semaglutide modulates explore/exploit decision-making in major depressive disorder: A randomized clinical trial
Randomized trial · Psychol Med · Oct 21, 2026 · Zhang Z et al.
- Response to Comment on Ganeshalingam et al. Semaglutide Effects on Insulin Sensitivity and β-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial With Semaglutide 1.0 mg Weekly
Randomized trial · Diabetes Care · Oct 20, 2026 · Ganeshalingam AA et al.
- Changes in Muscle Strength Following Semaglutide Treatment in Adults: A Systematic Review With Meta-Analysis of Handgrip Strength
Meta-analysis · Diabetes Obes Metab · Oct 19, 2026 · Machado LG et al.
- GLP-1 Receptor Agonist Therapy in Patients with Cancer: A Review of Clinical Outcomes
Systematic review · Int J Mol Sci · Oct 18, 2026 · Andronescu AC et al.
- Tolerability language and gastrointestinal risk in a meta-analysis of GLP-1 receptor agonists in antipsychotic-treated schizophrenia
Meta-analysis · Schizophr Res · Oct 18, 2026 · Cotrik E et al.
- The effect of glucagon-like peptide-1 receptor agonists versus metformin on pregnancy rates in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized trials
Meta-analysis · Eur J Obstet Gynecol Reprod Biol · Oct 15, 2026 · Kar E et al.
- Effects of tirzepatide (GIP/GLP-1 dual receptor agonist) on cardiorenal biomarkers and functional capacity in heart failure: a systematic review and meta-analysis
Meta-analysis · J Clin Endocrinol Metab · Oct 13, 2026 · Eisa N et al.
- Acute Effects of Acarbose and Canagliflozin, Alone and in Combination, on Postprandial GLP-1 and Glycaemic Responses in Post-Bariatric Hypoglycaemia: A Randomised Crossover Study
Randomized trial · Diabetes Obes Metab · Oct 12, 2026 · Yang W et al.
- Cutaneous Adverse Events Associated with Semaglutide, Liraglutide and Tirzepatide: A Systematic Review
Systematic review · Med Sci (Basel) · Oct 9, 2026 · Gupta AK et al.
- Effects of liraglutide on blood pressure and renal function in patients with type 2 diabetic nephropathy: a meta-analysis of randomized controlled trials
Meta-analysis · Front Med (Lausanne) · Oct 9, 2026 · Gao S et al.
- Impact of GLP-1 Receptor Agonists on Cognitive Performance in Adults at Risk of Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta-analysis · Nutrients · Oct 9, 2026 · Abbatecola AM et al.
- Efficacy and Safety of Chemically Synthesized Semaglutide Injection (HD1916) for the Treatment of Obesity: A Multicenter, Randomized, Phase III Trial
Randomized trial · Diabetes Obes Metab · Oct 7, 2026 · Gao L et al.
- GLP-1 receptor agonists for obstructive sleep apnea: a meta-analysis of randomized controlled trials
Meta-analysis · Sleep Breath · Oct 6, 2026 · Carvalhal G et al.
- Durability of Semaglutide Effects After Treatment Discontinuation in HIV-Associated Lipohypertrophy: A Randomized, Double-Blind, Placebo-Controlled Phase 2b Clinical Trial
Randomized trial · Open Forum Infect Dis · Oct 5, 2026 · Adekunle RO et al.
- [Efficacy and safety of GLP-1 receptor agonists combined with bariatric surgery for obesity: a timing-stratified systematic review]
Meta-analysis · Zhonghua Wei Chang Wai Ke Za Zhi · Oct 1, 2026 · He MC et al.
- Author Correction: Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial
Randomized trial · Nat Med · Oct 1, 2026 · Kaplan LM et al.
- Burden and Risk of Depression in Patients Receiving Semaglutide: A Systematic Review and Meta-Analysis
Meta-analysis · Clin Obes · Oct 1, 2026 · Bhaduri G et al.
- Comparative Efficacy of Tirzepatide Versus Semaglutide for Weight Loss in Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis of Head-to-Head Studies
Meta-analysis · Clin Obes · Oct 1, 2026 · Paccola GP et al.
- Effects of semaglutide on kidney disease in type 2 diabetes: a randomized placebo-controlled trial
Randomized trial · Nat Med · Oct 1, 2026 · Tuttle KR et al.
- Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH): A systematic review and meta-analysis
Meta-analysis · Medicine (Baltimore) · Oct 1, 2026 · Alfawaz M et al.
- Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND
Randomized trial · Diabetes Care · Oct 1, 2026 · Sattar N et al.
- Retatrutide and lipid and metabolite profiles in participants with obesity with or without type 2 diabetes
Randomized trial · J Clin Endocrinol Metab · Oct 1, 2026 · Pearson MJ et al.
- Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial
Randomized trial · Lancet · Sep 30, 2026 · Klein KR et al.
- Cutaneous Adverse Events With Semaglutide: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta-analysis · Cureus · Sep 30, 2026 · Ganjre S et al.
- Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial
Randomized trial · Lancet · Sep 29, 2026 · Bellido V et al.
- GLP-1 Receptor Agonists in Heart Failure: A Systematic Review and Meta-analysis with Phenotype-Specific Effects and Dual Analytical Frameworks
Meta-analysis · Drugs · Sep 26, 2026 · Yuan Y et al.
- Effects of Tirzepatide on Pancreatic β-Cell Function in Adults With Type 2 Diabetes Mellitus: A Systematic Review
Systematic review · Cureus · Sep 22, 2026 · Mahmoud R et al.
- Semaglutide Effects on Insulin Sensitivity and β-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial With Semaglutide 1.0 mg Weekly. Diabetes Care 2026;49:XXXX-XXXX
Randomized trial · Diabetes Care · Sep 21, 2026 · Chen L et al.
- Adjunctive GLP-1 receptor agonists for cardiometabolic risk in antipsychotic-treated patients: A GRADE-assessed meta-analysis of randomized trials
Meta-analysis · J Psychopharmacol · Sep 16, 2026 · Moubarak ES et al.
- Efficacy and safety of orforglipron 12 mg versus orforglipron 36 mg maintenance dose among patients with obesity with or without diabetes: a systematic review and comprehensive meta-analysis
Meta-analysis · BMC Endocr Disord · Sep 15, 2026 · Hegaz MG et al.
- Effects of Renin-Angiotensin Inhibitors, Sodium-Glucose Cotransporter 2 Inhibitors, Mineralocorticoid Receptor Antagonists and Glucagon-Like Peptide 1 Receptor Agonists on Kidney Outcomes in Patients With Type 1 Diabetes: A Systematic Review and Meta-Analysis
Meta-analysis · Diabetes Obes Metab · Sep 13, 2026 · Perry F et al.
- Tirzepatide and the Incidence of Atrial Fibrillation in Adults With Overweight or Obesity: An Updated Meta-Analysis of Randomized Controlled Trials
Meta-analysis · J Am Heart Assoc · Sep 9, 2026 · Mansouri ES et al.
- The effects of tirzepatide and semaglutide on clinical and metabolic outcomes in patients with heart failure with preserved ejection fraction and obesity: a systematic review and meta-analysis
Meta-analysis · Nutr Metab Cardiovasc Dis · Sep 8, 2026 · AlAraibi AJ et al.
- Comparative Efficacy and Safety of Liraglutide Versus Metformin in Women With Polyendocrine Metabolic Ovarian Syndrome (PMOS): A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta-analysis · Cureus · Sep 4, 2026 · Banerjee I et al.
- Safety and Glycemic Efficacy of Perioperative Liraglutide in Cardiac Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta-analysis · Cardiol Rev · Sep 4, 2026 · Gamal I et al.
- Cardiovascular and renal outcomes of GLP-1 receptor agonists in type 2 diabetes mellitus: a systematic review and meta-analysis
Meta-analysis · Eur Heart J Qual Care Clin Outcomes · Sep 1, 2026 · Ahmed M et al.
- Comparative Cardiovascular Outcomes of GLP-1 Receptor Agonists Versus Bariatric Surgery: A Systematic Review and Network Meta-Analysis
Meta-analysis · Endocrinol Diabetes Metab · Sep 1, 2026 · Shirmohammadi E et al.
- Effect of Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists on Myocardial Infarction and Stroke in Type 2 Diabetes: A Systematic Review and Meta-Analysis
Meta-analysis · Diabetes Ther · Sep 1, 2026 · Ghafoury R et al.
- Efficacy and Safety of Tirzepatide Versus Dulaglutide in Type 2 Diabetes With or Without Established Atherosclerotic Cardiovascular Disease: A Network Meta-Analysis of Randomized Clinical Trials
Meta-analysis · Endocrinol Diabetes Metab · Sep 1, 2026 · Hageen AW et al.
- Weight Regain Trajectories After Discontinuation of Semaglutide or Tirzepatide: A Reconstructed Aggregate-Data Bayesian Longitudinal Meta-Analysis
Meta-analysis · Endocrinol Diabetes Metab · Sep 1, 2026 · Kow CS et al.
- Association of tirzepatide with changes in OSA-related measures based on baseline characteristics - post hoc analyses of SURMOUNT-OSA
Randomized trial · J Clin Sleep Med · Aug 31, 2026 · Falcon B et al.
- Glycaemic Changes After Semaglutide Discontinuation in Adults With Type 1 Diabetes Using Automated Insulin Delivery: Analysis of the ADJUST-T1D Extension Study
Randomized trial · Diabetes Obes Metab · Aug 31, 2026 · Montaser E et al.
- Effects of semaglutide and empagliflozin on markers of endothelial function in persons with type 2 diabetes: A post hoc analysis of a randomized clinical trial
Randomized trial · J Diabetes Complications · Aug 29, 2026 · Gullaksen S et al.
- Long-Term Clinical Outcomes and Real-World Effectiveness of Tirzepatide in Adults With Overweight or Obesity: A Systematic Review
Systematic review · Cureus · Aug 22, 2026 · Olaniyi AO et al.
- Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial
Randomized trial · Lancet Diabetes Endocrinol · Aug 21, 2026 · Hsia SH et al.
- Dulaglutide vs insulin in adolescents with thalassaemia-induced diabetes: effect on metabolism and atherogenesis (DIADEMA)
Randomized trial · Diabetologia · Aug 19, 2026 · Adly AAM et al.
- Efficacy of Luseogliflozin Added to Semaglutide in Patients With Metabolic Dysfunction-Associated Steatohepatitis and Type 2 Diabetes Mellitus: A Randomised, Open-Label Trial
Randomized trial · Diabetes Obes Metab · Aug 17, 2026 · Miyake T et al.
- Efficacy of SGLT2 inhibitors, GLP-1 receptor agonists, and aerobic exercise for moderate-to-severe obstructive sleep apnea in overweight or obese patients: a network meta-analysis
Meta-analysis · Front Endocrinol (Lausanne) · Aug 17, 2026 · Zheng J et al.
- Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J): a multicentre, randomised, open-label, parallel-group phase 3 trial
Randomized trial · Lancet Diabetes Endocrinol · Aug 17, 2026 · Yabe D et al.
- Retatrutide-Associated Improvements in Cardiovascular Risk Biomarkers in Adults With Obesity With or Without Type 2 Diabetes
Randomized trial · Diabetes Obes Metab · Aug 17, 2026 · Ruotolo G et al.
- Effect of tirzepatide and semaglutide on blood pressure: A systematic review and meta-analysis
Meta-analysis · Endocrine · Aug 15, 2026 · Chen QX et al.
- Effects of Glucagon-Like Peptide-1 Receptor Agonists as Weight Loss Drugs on Pancreatitis and Pancreatic Cancer: A Meta-Analysis
Meta-analysis · Horm Metab Res · Aug 14, 2026 · Zhong X et al.
- Survodutide for Obesity in Chinese Adults: Phase 3 Randomized Trial Design and Baseline Characteristics (SYNCHRONIZE™-CN)
Randomized trial · Diabetes Ther · Aug 14, 2026 · Ji L et al.
- Comparative Efficacy and Safety of Tirzepatide Versus Semaglutide for Obesity: A Systematic Review
Systematic review · Cureus · Aug 13, 2026 · Mohamed Abdalla SA et al.
- Liraglutide and Βeta-Cell Function in Young Adults With Long-Standing Type 1 Diabetes and Residual C-Peptide: A Blinded, Randomized Controlled Trial
Randomized trial · Diabetes Obes Metab · Aug 13, 2026 · Caballero-Corbalán J et al.
- Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial
Randomized trial · Lancet Diabetes Endocrinol · Aug 10, 2026 · Guo L et al.
- Is There a Better Day of the Week to Administer Semaglutide or Tirzepatide? A Systematic Literature Review
Systematic review · Medicina (Kaunas) · Aug 10, 2026 · La Vignera S et al.
- Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis
Randomized trial · Lancet Diabetes Endocrinol · Aug 7, 2026 · Mann JFE et al.
- Analysis of the efficacy and safety of liraglutide, semaglutide, and tirzepatide for the treatment of overweight and obesity: a systematic review and network meta-analysis
Meta-analysis · J Endocrinol Invest · Aug 6, 2026 · Pałka W et al.
- Safety and Efficacy of Glucagon Like Peptide-1 Receptor Agonism-Based Therapies in End-Stage Renal Disease: A Systematic Review and Meta-Analysis
Meta-analysis · Endocr Pract · Aug 4, 2026 · Dutta D et al.
- Orforglipron Added to Titrated Insulin Glargine in Type 2 Diabetes: The ACHIEVE-5 Randomized Clinical Trial
Randomized trial · JAMA · Aug 1, 2026 · Giorgino F et al.
- Publisher Correction: Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial
Randomized trial · Nat Med · Aug 1, 2026 · Rosenstock J et al.
- Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity: The GLORY-2 Randomized Clinical Trial
Randomized trial · JAMA · Aug 1, 2026 · Gao L et al.
- Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial
Randomized trial · Am J Psychiatry · Jul 29, 2026 · Schacht JP et al.
- The comparative effectiveness of bariatric operations versus GLP-1 RAs: a systematic review and meta-analysis
Meta-analysis · Surg Obes Relat Dis · Jul 29, 2026 · Campbell C et al.
- GLP-1 receptor agonists in metabolic dysfunction-associated steatohepatitis: a systematic review and meta-analysis of randomized controlled trials
Meta-analysis · Hepatol Int · Jul 27, 2026 · Sun SP et al.
- Efficacy and Safety of Once-Weekly Semaglutide 2.0 mg as an Add-On to Dose-Reduced Insulin Glargine versus Dose-Titrated Insulin Glargine in People With Type 2 Diabetes and Overweight (SUSTAIN OPTIMIZE)
Randomized trial · Diabetes Obes Metab · Jul 26, 2026 · Rodbard HW et al.
- GLP-1 agonists for smoking cessation and post-cessation weight management: A systematic review and meta-analysis of randomized trials
Meta-analysis · Tob Induc Dis · Jul 26, 2026 · Heshmati J et al.
- Effects of glucagon-like peptide-1 receptor agonists on metabolic outcomes in antipsychotic-treated patients with schizophrenia: A systematic review and meta-analysis
Meta-analysis · Schizophr Res · Jul 24, 2026 · Sobral MVS et al.
- Efficacy and safety of mazdutide vs. dulaglutide in adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
Meta-analysis · Diabetol Metab Syndr · Jul 24, 2026 · Hassan M et al.
- The glucagon and GLP-1 receptor dual agonist DD01 for metabolic dysfunction-associated steatotic liver disease and steatohepatitis (DD01-DN-02): 12-week results from a randomised, double-blind, multicentre, placebo-controlled, phase 2 trial
Randomized trial · Lancet Gastroenterol Hepatol · Jul 21, 2026 · Noureddin M et al.
- Correction: Comparative analysis of glucagon-like peptide-1 receptor agonists, metformin, and inositol in improving anthropometric and metabolic outcomes in women with polycystic ovary syndrome: a network meta-analysis
Meta-analysis · Front Endocrinol (Lausanne) · Jul 20, 2026 · Omarion A et al.
- Insulin, Semaglutide and Dapagliflozin in Adults With Type 1 Diabetes: Design and Methods of Triple Therapy for Type 1 Diabetes (TTT1)-An International Phase 3 Clinical Trial
Randomized trial · Diabetes Obes Metab · Jul 19, 2026 · Timmons JG et al.
- Efficacy and safety of zalfermin co-administered with semaglutide in participants with fibrosis and cirrhosis due to metabolic dysfunction-associated steatohepatitis: a phase 2, dose-ranging, double-blind, randomised controlled trial
Randomized trial · Lancet Gastroenterol Hepatol · Jul 15, 2026 · Loomba R et al.
- Exploratory Cardiovascular Risk Modeling of Orforglipron Using the PREVENT Equations Compared with the Pooled Cohort Equations: A Post-Hoc Analysis from a Systematic Review and Meta-analysis
Meta-analysis · High Blood Press Cardiovasc Prev · Jul 15, 2026 · Alper A et al.
- Comparative Outcomes of Metabolic and Bariatric Surgery Versus GLP-1 Receptor Agonists: An Updated Systematic Review and Meta-Analysis of 14,548 Patients
Meta-analysis · J Laparoendosc Adv Surg Tech A · Jul 14, 2026 · Rivero-Moreno Y et al.
- Tirzepatide, cardiovascular outcomes and mortality in obesity and diabetes: a systematic review and meta-analysis
Meta-analysis · Diabetes Res Clin Pract · Jul 13, 2026 · Spiazzi BF et al.
- Combination Therapy of GLP-1 RA and SGLT2i in Patients with Established Heart Failure: A Systematic Review and Meta-Analysis of Observational Studies
Meta-analysis · Am J Cardiovasc Drugs · Jul 10, 2026 · Tristan CD et al.
- Efficacy and Safety of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Ventricular Arrhythmias and Cardiovascular Events: A Disease-Stratified Network Meta-Analysis
Meta-analysis · Diabetes Obes Metab · Jul 9, 2026 · Sun WT et al.
- Coronary artery disease -related outcomes associated with semaglutide and tirzepatide in type 2 diabetes mellitus and obesity: a systematic review and meta-analysis
Meta-analysis · Nutr Metab Cardiovasc Dis · Jul 7, 2026 · Zhou XY et al.
- Glucagon-Like Peptide-1 (GLP-1)-Based Therapies and Heart Failure Outcomes: A Scoping Review of Contemporary Randomized Controlled Trials
Randomized trial · Cureus · Jul 7, 2026 · Patel J et al.
- Cardiovascular Outcomes With Tirzepatide Versus GLP-1 Receptor Agonists in Overweight or Obesity: A Systematic Review and Meta-Analysis
Meta-analysis · Diabetes Obes Metab · Jul 6, 2026 · Silva JPMRJ et al.
- Efficacy and Safety of the Dual Glucagon-Like Peptide-1 and Glucagon Receptor Agonist Mazdutide in Predominantly Chinese Adults With Obesity and/or Type 2 Diabetes: A Systematic Review and Meta-Analysis
Meta-analysis · Diabetes Obes Metab · Jul 6, 2026 · Kamrul-Hasan ABM et al.
- GLP-1 receptor agonist therapy in children and adolescents with obesity: A network meta-analysis of differential cardiometabolic efficacy and safety profiles
Meta-analysis · Pharmacol Res · Jul 4, 2026 · Li Y et al.
- Comparative analysis of glucagon-like peptide-1 receptor agonists, metformin, and inositol in improving anthropometric and metabolic outcomes in women with polycystic ovary syndrome: a network meta-analysis
Meta-analysis · Front Endocrinol (Lausanne) · Jul 3, 2026 · Omarion A et al.
- Effects of GLP-1 Receptor Agonists on Psoriasis: An "Agent-Specific" Systematic Review of the Literature
Systematic review · J Clin Med · Jul 1, 2026 · Marani A et al.
- Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical Trial
Randomized trial · JAMA Dermatol · Jul 1, 2026 · Lebwohl M et al.
- Metabolic and Glycemic Effects of Orforglipron, a GLP-1 Receptor Agonist, in Adults With or Without Diabetes: A Network Meta-Analysis of Randomised Clinical Trials
Meta-analysis · Endocrinol Diabetes Metab · Jul 1, 2026 · Hageen AW et al.
- Therapeutic role of semaglutide in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis of placebo-controlled trials with GRADE evidence assessment
Meta-analysis · Medicine (Baltimore) · Jul 1, 2026 · Khan S et al.
- Effect of Retatrutide, a Novel Triple Receptor Agonist, on Blood Pressure and Lipid Levels: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Meta-analysis · High Blood Press Cardiovasc Prev · Jun 29, 2026 · Simental-Mendía LE et al.
- Efficacy and Safety of Dual and Triple Glucagon-Like Peptide-1-Based Polyagonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis: A Systematic Review and Meta-Analysis
Meta-analysis · Cureus · Jun 29, 2026 · Santos Solis R et al.